Literature DB >> 17931734

Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans.

Peter Kovacs1, Rahel Kress, Jacqueline Rocha, Ulrike Kurtz, Juan Francisco Miquel, Flavio Nervi, Nahum Méndez-Sánchez, Misael Uribe, Hans H Bock, Ramin Schirin-Sokhan, Michael Stumvoll, Joachim Mössner, Frank Lammert, Henning Wittenburg.   

Abstract

BACKGROUND/AIMS: From quantitative trait locus mapping in inbred mice, we identified the Nr1h4 gene encoding the nuclear bile salt receptor FXR as a candidate gene for the cholesterol gallstone susceptibility locus Lith7. Here, we investigated further an association of the gene encoding FXR and gallstone susceptibility in mice and humans.
METHODS: The Nr1h4 gene was sequenced in inbred mouse strains with susceptible and resistant Lith7 alleles. Quantitative RT-PCR was employed to determine mRNA expression levels. Gallstone carriers and control subjects of three different populations comprising 1004 individuals were genotyped for polymorphisms of the orthologous human gene detected by sequencing.
RESULTS: Expression and sequence analyses in inbred mice were consistent with Nr1h4 underlying Lith7. In the human populations, we identified three frequent haplotypes that accounted for > 95% of all haplotypes observed. In a Mexican population, the most common haplotype NR1H4_1 was associated with gallstone prevalence. In contrast, NR1H4_1 displayed no association with gallstone prevalence in a German population, whereas in a Chilean population we observed a trend towards a protective effect of NR1H4_1.
CONCLUSIONS: Our study in an inbred mouse model and in three ethnically distinct populations indicates complex interactions of NR1H4 alleles and other risk factors for the development of cholelithiasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17931734     DOI: 10.1016/j.jhep.2007.07.027

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  22 in total

1.  A novel heterozygous NR1H4 termination codon mutation in idiopathic infantile cholestasis.

Authors:  Xiu-Qi Chen; Lin-Lin Wang; Qing-Wen Shan; Qing Tang; Ya-Nan Deng; Shu-Jun Lian; Xiang Yun
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  Concept of the pathogenesis and treatment of cholelithiasis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Hepatol       Date:  2012-02-27

Review 3.  Targets for current pharmacologic therapy in cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q H Wang; Helen H Wang; Leonilde Bonfrate; Piero Portincasa
Journal:  Gastroenterol Clin North Am       Date:  2010-06       Impact factor: 3.806

4.  Activation of the farnesoid X receptor provides protection against acetaminophen-induced hepatic toxicity.

Authors:  Florence Ying Lee; Thomas Quad de Aguiar Vallim; Hansook Kim Chong; Yanqiao Zhang; Yaping Liu; Stacey A Jones; Timothy F Osborne; Peter A Edwards
Journal:  Mol Endocrinol       Date:  2010-06-23

5.  Depletion of hepatic forkhead box O1 does not affect cholelithiasis in male and female mice.

Authors:  Xiaoyun Feng; Cuiling Zhu; Sojin Lee; Jingyang Gao; Ping Zhu; Jun Yamauchi; Chenglin Pan; Sucha Singh; Shen Qu; Rita Miller; Satdarshan P Monga; Yongde Peng; H Henry Dong
Journal:  J Biol Chem       Date:  2020-04-09       Impact factor: 5.157

Review 6.  FXR signaling in the enterohepatic system.

Authors:  Tsutomu Matsubara; Fei Li; Frank J Gonzalez
Journal:  Mol Cell Endocrinol       Date:  2012-05-17       Impact factor: 4.102

Review 7.  Tissue-specific function of farnesoid X receptor in liver and intestine.

Authors:  Yan Zhu; Fei Li; Grace L Guo
Journal:  Pharmacol Res       Date:  2011-01-04       Impact factor: 7.658

8.  The G protein-coupled receptor G2A: involvement in hepatic lipid metabolism and gallstone formation in mice.

Authors:  Laura E Johnson; Marc S Elias; David T Bolick; Marcus D Skaflen; Richard M Green; Catherine C Hedrick
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

9.  Regulation of human class I alcohol dehydrogenases by bile acids.

Authors:  Cédric Langhi; Elena Pedraz-Cuesta; Diego Haro; Pedro F Marrero; Joan C Rodríguez
Journal:  J Lipid Res       Date:  2013-06-16       Impact factor: 5.922

10.  A variant of the SLC10A2 gene encoding the apical sodium-dependent bile acid transporter is a risk factor for gallstone disease.

Authors:  Olga Renner; Simone Harsch; Elke Schaeffeler; Stefan Winter; Matthias Schwab; Marcin Krawczyk; Jonas Rosendahl; Henning Wittenburg; Frank Lammert; Eduard F Stange
Journal:  PLoS One       Date:  2009-10-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.